JPMORGAN CHASE & CO
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 499,982 | 58.0 |
| Stockholders' equity | 362,438 | 42.0 |
| Total capitalization | 862,420 | 100.0 |
2,658,186,195 shares outstanding at 30 June 2026 (cover page of the 10-Q filed 6 August 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 435,206 |
| Short-term borrowings / commercial paper | 64,776 |
CAPITAL STOCK 12/31/25
| Common shares authorized | 9,000,000,000 |
| Common shares issued | 4,104,933,895 |
| Treasury shares | 1,408,661,319 |
| Par or stated value per share ($) | 1 |
| Outstanding at 6/30/26 | 2,658,186,195 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | 5.80 | 29.0 |
| 2024 | 4.80 | 24.3 |
| 2023 | 4.10 | 25.3 |
| 2022 | 4.00 | 33.1 |
| 2021 | 3.80 | 24.7 |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware. Formerly known as CHASE MANHATTAN CORP /DE/ (to 21 November 2000); CHEMICAL BANKING CORP (to 28 March 1996).
BUSINESS: Classified by the SEC under Standard Industrial Classification 6021, National Commercial Banks. Large accelerated filer. Principal executive office: 270 Park Avenue, New York, NY 10017. Fiscal year ends December 31. Deposits at 12/31/25: $2,559,320 million. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Total interest income | 193,341 | 193,933 | 170,588 |
| Total interest expense | 97,898 | 101,350 | 81,321 |
| Net interest income | 95,443 | 92,583 | 89,267 |
| Provision for credit losses | 14,212 | 10,678 | 9,320 |
| Noninterest income | 87,004 | 84,973 | 68,837 |
| Noninterest expense | 95,640 | 91,797 | 87,172 |
| Total net revenue | 182,447 | 177,556 | 158,104 |
| Income before income taxes | 72,595 | 75,081 | 61,612 |
| Income taxes | 15,547 | 16,610 | 12,060 |
| Net income | 57,048 | 58,471 | 49,552 |
| Earned per share, diluted ($) | 20.02 | 19.75 | 16.23 |
| Dividends per share ($) | 5.80 | 4.80 | 4.10 |
CONSOLIDATED STATEMENT OF CONDITION
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Cash and due from banks | 21,742 | 23,372 |
| Interest-bearing deposits with banks | 321,596 | 445,945 |
| Loans | 1,408,905 | 1,299,590 |
| Allowance for credit losses | 25,765 | 24,345 |
| Total assets | 4,424,900 | 4,002,814 |
| Deposits | 2,559,320 | 2,406,032 |
| Short-term borrowings | 64,776 | 52,893 |
| Long-term debt | 435,206 | 401,418 |
| Total liabilities | 4,062,462 | 3,658,056 |
| Stockholders' equity | 362,438 | 344,758 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Total assets | Total liabilities | Total debt | Deposits | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 182,447 | – | 57,048 | 31.3 | 20.02 | 5.80 | (147,782) | 4,424,900 | 4,062,462 | 499,982 | 2,559,320 | 362,438 | 15.7 | 1.38 |
| 12/31/24 | 177,556 | – | 58,471 | 32.9 | 19.75 | 4.80 | (42,012) | 4,002,814 | 3,658,056 | 454,311 | 2,406,032 | 344,758 | 17.0 | 1.32 |
| 12/31/23 | 158,104 | – | 49,552 | 31.3 | 16.23 | 4.10 | 12,974 | 3,875,393 | 3,547,515 | 436,537 | 2,400,688 | 327,878 | 15.1 | 1.33 |
| 12/31/22 | 128,695 | – | 37,676 | 29.3 | 12.09 | 4.00 | 107,119 | 3,665,743 | 3,373,411 | 339,892 | 2,340,179 | 292,332 | 12.9 | 1.16 |
| 12/31/21 | 121,649 | – | 48,334 | 39.7 | 15.36 | 3.80 | 78,084 | 3,743,567 | 3,449,440 | 354,599 | 2,462,303 | 294,127 | 16.4 | 1.21 |
| 12/31/20 | 119,951 | – | 29,131 | 24.3 | 8.88 | 3.60 | (79,910) | 3,384,757 | 3,105,403 | 326,893 | 2,144,257 | 279,354 | 10.4 | 1.17 |
| 12/31/19 | 115,720 | – | 36,431 | 31.5 | 10.72 | 3.40 | 4,092 | 2,686,477 | 2,426,049 | 332,418 | 1,562,431 | 261,330 | 13.9 | 1.27 |
| 12/31/18 | 108,783 | – | 32,474 | 29.9 | 9.00 | 2.72 | 15,614 | 2,622,532 | 2,366,017 | 351,307 | 1,470,666 | 256,515 | 12.7 | 1.37 |
| 12/31/17 | 100,705 | – | 24,441 | 24.3 | 6.31 | 2.12 | (10,827) | 2,533,600 | 2,277,907 | 335,882 | 1,443,982 | 255,693 | 9.6 | 1.31 |
| 12/31/16 | 96,569 | – | 24,733 | 25.6 | 6.19 | 1.88 | 21,884 | 2,490,972 | 2,236,782 | 329,688 | 1,375,179 | 254,190 | 9.7 | 1.30 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; capital expenditure and free cash flow are not shown for banks and insurers, where they are not meaningful; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
JPMORGAN CHASE & CO
CIK 19617 · EIN 13-2624428
PRINCIPAL OFFICE:
270 Park Avenue, New York, NY 10017
Tel.: 2122706000
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
6021 · National Commercial Banks
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 13 February 2026
FORMER NAMES:
JPMORGAN CHASE & CO; J P MORGAN CHASE & CO; CHASE MANHATTAN CORP /DE/
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/13/26) · 10-K FY2024 (filed 2/14/25) · 10-K FY2023 (filed 2/16/24) · 10-K FY2022 (filed 2/21/23) · 10-K FY2021 (filed 2/22/22) · 10-K FY2020 (filed 2/23/21) · 10-K FY2019 (filed 2/25/20) · 10-K FY2018 (filed 2/26/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.